logo

Wockhardt swings to profit in Q2, novel antibiotic Zaynich gets breakthrough status in Saudi Arabia

Revenue for the quarter stood at ₹782 crore, up from ₹738 crore in Q1. EBITDA margins improved to 20.5%, up from 13.7% in the previous quarter.

Read Full

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *